Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5-FU) and cisplatin for locally advanced resectable esophageal cancer

BACKGROUND: Neoadjuvant concurrent chemoradiotherapy (CCRT) has become the standard treatment for esophageal cancer (EC) in North America. The cisplatin/5-flurouracil (5-FU) combination has been the most commonly used regimen. For the last 15 years we incorporated a daily continuous infusion of 5-FU...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Gastrointest Oncol
Hlavní autoři: Almhanna, Khaldoun, Hoffe, Sarah, Strosberg, Jonathan, Dinwoodie, William, Meredith, Kenneth, Shridhar, Ravi
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4294830/
https://ncbi.nlm.nih.gov/pubmed/25642336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2014.101
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky